Remdesivir for the Treatment of Covid-19 - Preliminary Report.

Simple item page
dc.contributor.authorOlalla, Julián
dc.date.accessioned2025-01-07T14:49:01Z
dc.date.available2025-01-07T14:49:01Z
dc.date.issued2020-07-10
dc.identifier.doi10.1056/NEJMc2022236
dc.identifier.essn1533-4406
dc.identifier.pmid32649077
dc.identifier.unpaywallURLhttps://www.nejm.org/doi/pdf/10.1056/NEJMc2022236?articleTools=true
dc.identifier.urihttps://hdl.handle.net/10668/26677
dc.issue.number10
dc.journal.titleThe New England journal of medicine
dc.journal.titleabbreviationN Engl J Med
dc.language.isoen
dc.organizationSAS - Hospital Costa del Sol
dc.page.number993-994
dc.pubmedtypeLetter
dc.pubmedtypeComment
dc.rights.accessRightsopen access
dc.subject.meshAdenosine Monophosphate
dc.subject.meshAlanine
dc.subject.meshBetacoronavirus
dc.subject.meshCOVID-19
dc.subject.meshCoronavirus Infections
dc.subject.meshHumans
dc.subject.meshPandemics
dc.subject.meshPneumonia, Viral
dc.subject.meshSARS-CoV-2
dc.subject.meshCOVID-19 Drug Treatment
dc.titleRemdesivir for the Treatment of Covid-19 - Preliminary Report.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number383

Files

Collections

SAS - Hospital Costa del Sol

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía